In COVID-19 clinical update #63, Daniel Griffin reviews cases at child care facilities, estimates of mRNA vaccine effectiveness, risk of reinfection in university students, enhanced antibody generation with extended interval of mRNA vaccination, no benefit of convalescent plasma in hospitalized patients, and risk of clinical sequelae after acute infection.
A physician-scientist, board certified in Infectious Disease w expertise in Global Health, Tropical Medicine, Parasitology, and Virology. Vaccinated-Moderna
